INTC stock surged +48% over the past 30 days, driven by a historic nine-day winning streak amid AI chip deals and analyst upgrades. Over the past quarter, shares rose +45%, recovering from an early post-earnings drop through foundry progress and product launches.

UNH stock price surged +30% over the past 30 days, driven by a strong Q1 2026 earnings beat and raised full-year profit guidance. Over the past quarter, the stock declined -1%, marked by high volatility including a sharp early-year drop followed by a partial recovery.

Analysts expect Q3 FY2026 revenue of $3.23 billion, in line with company guidance of $3.1 billion to $3.3 billion. Consensus EPS (earnings per share) estimate stands at $2.34, reflecting over 70% year-over-year (YoY) growth.

Avis Budget Group (CAR) shares are plunging approximately 37% in Thursday's session, extending a violent collapse that began after the stock hit an all-time intraday high of $847.70 on April 22, 2026. The primary catalyst is the unwinding of one of the most extreme short squeezes in modern U.S. market history, which had driven CAR from under $100 to nearly $850 in approximately four weeks.

lululemon athletica (LULU) shares are trading down approximately 12% on April 23, 2026, falling from a prior close of $163.45 to a fresh 52-week low near $143.84. The primary catalyst is the announcement of Heidi O'Neill, a former Nike executive, as the company's next CEO, effective September 8, 2026 — a choice that left investors underwhelmed and deepened concerns about the pace of the company's turnaround.

Atlassian Corporation (TEAM) shares are down approximately 11% on April 23, 2026, falling from a prior close of $71.22 to around $63.39, pushing the stock toward new multi-year lows. The primary catalyst is sector contagion: ServiceNow (NOW) plunged over 12% after reporting Q1 2026 earnings that flagged delayed deal closures tied to Middle East geopolitical disruptions, triggering a broad selloff across enterprise software and SaaS names.

Freeport-McMoRan (FCX) shares are trading down approximately 11% in Thursday's session, falling from a prior close of $70.36 to around $62.62. The primary catalyst is a major downward revision to full-year 2026 copper and gold sales guidance, driven by further operational setbacks at the flagship Grasberg Block Cave mine in Indonesia.

TDY stock rose approximately +5% over the past 30 days, primarily fueled by a strong first-quarter earnings beat and raised full-year guidance. The stock gained about +8% over the past quarter, supported by sustained demand in defense and aerospace sectors.

Medpace Holdings (MEDP) shares are trading down approximately 22% in pre-market on April 23, 2026, from a prior close of $508.46, implying a pre-market price near $397. The primary catalyst is a sub-1.0 net book-to-bill ratio of 0.88x in Q1 2026 — a closely watched metric that signals new bookings fell short of recognized revenue, raising concerns about future backlog growth and revenue sustainability.

AAR Corp. (AIR) stock rose +3.4% over the past 30 days amid strong quarterly earnings and new defense contracts, though recent volatility pulled back gains from a mid-April peak.

BA stock rose +18% over the past 30 days, propelled by a Q1 earnings beat with revenue up 14% year-over-year and narrower-than-expected losses. Jet deliveries accelerated, boosting investor confidence in commercial recovery amid strong aircraft backlog.

NOC stock declined -14% over the past 30 days, driven by a post-earnings selloff despite beating Q1 estimates, amid broader defense sector weakness. Over the past quarter, shares fell -12% after peaking mid-period, reflecting initial gains from strong backlog growth followed by market rotation out of defensives.

LHX stock declined 5.6% over the past 30 days, reflecting a broader pullback in defense sector stocks amid shifting market sentiment. Over the past quarter, shares fell 6.5%, following a peak in early March driven by strong defense demand before recent declines.

LITE maintains a strong bullish uptrend, with shares trading well above key moving averages, including the 50-day MA near 729 and 200-day SMA around 779. RSI(14) at 54.6 signals neutral momentum, avoiding overbought conditions amid the rally.

FormFactor shares have surged significantly in recent weeks, driven by robust demand for its semiconductor testing solutions in AI applications. Upcoming first-quarter 2026 earnings on April 29 represent a pivotal catalyst for further price movement.

SIMO remains in a strong uptrend, with shares trading near recent highs after surging over 57% year-to-date and 270% over the past year. Price holds above key moving averages, including the 50-day at approximately 137 and 200-day at 124, signaling sustained bullish momentum.

Super Micro Computer (SMCI) shares are trading down approximately 10% in pre-market on April 23, 2026, following a prior close of $29.18. The decline reflects a confluence of factors: sector-wide selloff triggered by ServiceNow's sharp post-earnings drop on geopolitical guidance concerns, which dragged AI infrastructure and enterprise IT names broadly lower.

ServiceNow (NOW) shares are trading down approximately 12.81% in pre-market on April 23, 2026, falling from a prior close of $103.07 to around $89.87. The primary catalyst is the company's Q1 2026 earnings report, released after the close on April 22, which revealed subscription revenue growth was dinged by a ~75 basis point headwind from delayed large on-premise deal closures in the Middle East due to the ongoing regional conflict.

Shares of IOVA are declining approximately 6.49% in Wednesday's session on April 22, 2026, falling from a prior close of $3.70 to approximately $3.46, as broad biotech sector selling pressure and risk-off sentiment weigh on commercial-stage but unprofitable biopharmaceutical companies.

Shares of SMMT are declining approximately 9.51% in Wednesday's session on April 22, 2026, falling from a prior close of $26.38 to approximately $23.87, as investors lock in gains following the stock's sharp 16.4% single-session surge on April 21. The primary driver is profit-taking after an outsized upside move: SMMT surged from approximately $22.65 to $26.38 on April 21 on renewed investor enthusiasm surrounding ivonescimab's clinical data potential and bullish institutional commentary — gains that are now partially being retraced in the absence of a new positive catalyst.